LGND: Ligand Pharmaceuticals Inc.
Performance
LGND +55.15%
Watchlist
Select an item
Summary
LGND at a glance
LGND returned +55.15% over the past year and +15.40% a year over five years. Its worst drop in that year was -14.70%, smaller than 92% of stocks on Redstone, and its Sharpe ratio of 1.29 beats 86% of stocks on Redstone. It pays no dividends.
Current Drawdown
-2.66%
Rolling Volatility
39.74%
Actions
Metrics
Risk Indicators
Alpha38.17%
Beta0.91x
Sharpe1.29
Sortino1.91
Omega1.23
Calmar3.75
Martin6.43
Profile
About LGND
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $6.3B
- Listed
- Nov 1994
- Employees
- 47
- Headquarters
- San Diego, CA
- Website
- ligand.com
Comparisons